A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382

NCT01482611 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Virus Infection

Interventions

DRUG: JNJ-47910382
DRUG: JNJ-47910382
DRUG: JNJ-47910382
DRUG: JNJ-47910382
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo

Sponsor

Janssen R&D Ireland